Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease

JAMA Neurology

Volumn 70, Issue 4, 2013, Pages 440-444

  Zlokovic, Berislav V ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CYCLOPHILIN A; GELATINASE B; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEGALIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 84876136764     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.2152     Document Type: Article

References (18)

1. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res. 2009;50(suppl):S183-S188.
2. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009;63(3):287-303.
3. Tanzi RE. The genetics of Alzheimer disease [published July 25, 2012]. Cold Spring Harb Perspect Med. doi:10.1101/cshperspect.a006296.
4. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011;10(3):241-252.
5. Guerreiro R, Wojtas A, Bras J, et al; the Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer's disease [published online November 14, 2012]. N Engl J Med. doi:10.1056/NEJMoa1211851.
6. Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of Alzheimer's disease [published online November 14, 2012]. N Engl J Med. doi:10.1056/NEJMoa1211103.
7. Farrer LA, Cupples LA, Haines JL, et al; APOE and Alzheimer Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349-1356. (Pubitemid 27449696)
8. Genin E, Hannequin D, Wallon D, et al. APOE and Alzheimer disease: a major gene with semidominant inheritance. Mol Psychiatry. 2011;16(9):903-907.
9. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12(12):723-738.
10. Zloković BV, Lipovac MN, Begley DJ, Davson H, Rakić L. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain. J Neurochem. 1987;49(1):310-315. (Pubitemid 17108265)
11. Bell RD, Winkler EA, Sagare AP, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010;68(3):409-427.
12. Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci. 2011;14(11):1398-1405.
13. Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485(7399):512-516.
14. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV. Deficiency in muralvas cular cells coincides with blood-brain barrier disruption in Alzheimer's disease [published online November 5, 2012]. Brain Pathol. doi:10.1111/bpa.12004.
15. Zipser BD, Johanson CE, Gonzalez L, et al. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging. 2007;28(7):977-986. (Pubitemid 46635913)
16. Deane R, Sagare A, Hamm K, et al. apoE isoformspecific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008;118(12):4002-4013.
17. Castellano JM, Kim J, Stewart FR, et al. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med. 2011;3(89):ra57.
18. Bell RD, Sagare AP, Friedman AE, et al. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab. 2007;27(5):909-918. (Pubitemid 46659038)